Prophylactic Ceftizoxime (Cefizox) for Elective Cesarean Delivery

NCT ID: NCT01347593

Last Updated: 2013-01-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

220 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-05-31

Study Completion Date

2011-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Ceftizoxime (Cefizox) will reduce post Cesarean delivery febrile morbidity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Caesarean

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ceftizoxime (cefizox) injection

ceftizoxime (cefizox) as single dose of 1 g at the interval of 30-60 minutes before the incision

Group Type EXPERIMENTAL

ceftizoxime

Intervention Type DRUG

ceftizoxime (cefizox) injection either after clamping the cord

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ceftizoxime

ceftizoxime (cefizox) injection either after clamping the cord

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

cefizox

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Elective Cesarean section

Exclusion Criteria

* Diabetes severe anaemia allergy
Minimum Eligible Age

14 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ministry of Health, Sudan

UNKNOWN

Sponsor Role collaborator

University of Khartoum

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ishag Adam

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Soba Hospital

Khartoum, Khartoum State, Sudan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sudan

References

Explore related publications, articles, or registry entries linked to this study.

Osman B, Abbas A, Ahmed MA, Abubaker MS, Adam I. Prophylactic ceftizoxime for elective cesarean delivery at Soba Hospital, Sudan. BMC Res Notes. 2013 Feb 8;6:57. doi: 10.1186/1756-0500-6-57.

Reference Type DERIVED
PMID: 23394621 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ceftizoxime cesarean

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Prophylactic Antibiotics After Cesarean
NCT03187106 COMPLETED PHASE1
Dexmedetomidine for Cesarean Delivery
NCT01005433 COMPLETED PHASE1